Category: CNS/Neurology
CNS/Neurology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Neurology
The 2025-2030 World Outlook for Neurology This study covers the world outlook for neurology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More
-
The 2025-2030 World Outlook for Neurological Disorder Drugs
The 2025-2030 World Outlook for Neurological Disorder Drugs This study covers the world outlook for neurological disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Drugs for Parkinson's Diseases
The 2025-2030 World Outlook for Neurodegenerative Drugs for Parkinson's Diseases This study covers the world outlook for neurodegenerative drugs for Parkinson's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders This study covers the world outlook for therapeutic plasma exchange for neurological disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Therapeutics
The 2025-2030 World Outlook for Schizophrenia Therapeutics This study covers the world outlook for schizophrenia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Drugs
The 2025-2030 World Outlook for Schizophrenia Drugs This study covers the world outlook for schizophrenia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Neurology Devices
The 2025-2030 World Outlook for Neurology Devices This study covers the world outlook for neurology devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Neurology Monitoring Devices
The 2025-2030 World Outlook for Neurology Monitoring Devices This study covers the world outlook for neurology monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Neurology Ultrasonic Aspirators
The 2025-2030 World Outlook for Neurology Ultrasonic Aspirators This study covers the world outlook for neurology ultrasonic aspirators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Bioelectric Medicines
The 2025-2030 World Outlook for Bioelectric Medicines This study covers the world outlook for bioelectric medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neurorehabilitation Neurorobotic Systems
The 2025-2030 World Outlook for Neurorehabilitation Neurorobotic Systems This study covers the world outlook for neurorehabilitation neurorobotic systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Clozapine
The 2025-2030 World Outlook for Clozapine This study covers the world outlook for clozapine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More
-
The 2025-2030 World Outlook for CNS Therapeutics
The 2025-2030 World Outlook for CNS Therapeutics This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Nootropics
The 2025-2030 World Outlook for Nootropics This study covers the world outlook for nootropics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Cognition and Memory-Enhancing Drugs
The 2025-2030 World Outlook for Cognition and Memory-Enhancing Drugs This study covers the world outlook for cognition and memory-enhancing drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Amyotrophic Lateral Sclerosis Treatments
The 2025-2030 World Outlook for Amyotrophic Lateral Sclerosis Treatments This study covers the world outlook for amyotrophic lateral sclerosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Disorders
The 2025-2030 World Outlook for Neurodegenerative Disorders This study covers the world outlook for neurodegenerative disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Neuroprotective Agents
The 2025-2030 World Outlook for Neuroprotective Agents This study covers the world outlook for neuroprotective agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Tinnitus Management
The 2025-2030 World Outlook for Tinnitus Management This study covers the world outlook for tinnitus management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Antidepressants for Major Depressive Disorders
The 2025-2030 World Outlook for Antidepressants for Major Depressive Disorders This study covers the world outlook for antidepressants for major depressive disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Brain Mapping Instruments
The 2025-2030 World Outlook for Brain Mapping Instruments This study covers the world outlook for brain mapping instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia
The 2025-2030 World Outlook for Antiepileptic Therapeutics for Fibromyalgia This study covers the world outlook for antiepileptic therapeutics for fibromyalgia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Migraine Drugs
The 2025-2030 World Outlook for Migraine Drugs This study covers the world outlook for migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Brain Health Supplements
The 2025-2030 World Outlook for Brain Health Supplements This study covers the world outlook for brain health supplements across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Narcolepsy Drugs
The 2025-2030 World Outlook for Narcolepsy Drugs This study covers the world outlook for narcolepsy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
Research Assistance
